ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

HYALGAN
Arthritis/rheumatic disorders
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

HYALGAN Rx

Generic Name and Formulations:
Sodium hyaluronate 20mg/2mL; soln for intra-articular inj.

Company:
Sanofi U.S.

Therapeutic Use:

Indications for HYALGAN:

Osteoarthritis of the knee in patients who have failed nonpharmacologic therapy and analgesics (eg, acetaminophen).

Adult:

Prior to treatment: remove joint effusion (use separate syringe), if present; and give local anesthetic (eg, lidocaine) by SC inj. Inject 2mL intra-articularly in each affected knee weekly for 5 weeks. Use separate syringes for each knee.

Children:

Not recommended.

Contraindications:

Infection or skin disease at inj site.

Warnings/Precautions:

Treatment cycle <3 injections: not recommended. Avian protein, feather, egg allergy. Avoid strenuous activity within 48hrs after injection. Pregnancy. Nursing mothers.

Pharmacological Class:

Hyaluronan.

Interactions:

Avoid disinfectants with quaternary ammonium salts. Concomitant other intra-articular injectables: not recommended.

Adverse Reactions:

Inj site pain, local reactions, transient knee inflammation.

Generic Availability:

NO

How Supplied:

Single-use vials—1; Single-use prefilled syringes—1


Data provided by MPR.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs